Generation Lab, a San Francisco, CA-based provider of a test based on clinically relevant biological evidence, raised an undisclosed amount to Pre-Seed funding.
Backers included Transpose Platform and Sequoia China Founding Partner.
The company intends to use the funds to expand operations and its development efforts.
Co-founded by Irina Conboy, Alina Rui Su and Michael Suswal, Generation Lab aims to extend the human healthspan with the first test based on clinically relevant biological evidence that measures individuals’ biological age progression and risk of disease so everyone can live longer, healthier lives. It combines a simple cheek-swab test with proprietary techniques to definitively measure molecular disbalance that indicates aging and risk of disease.
The company, which works with clinicians who can recommend personalized interventions, and Generation Lab can measure the effectiveness of these over time, expects its aging test kits to be available in Q1 2024.
FinSMEs
30/01/2024